Director, Clinical Operations – Phase III Oncology

Eliassen Group

Boise (ID)

Remote

USD 207,000 - 220,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Medical Insurance
Dental Insurance
Vision Insurance
401k with match
Life Insurance

Job summary

Eliassen Group is seeking a Director, Clinical Operations to lead the execution of a large global Phase III breast cancer study. You will drive study start-up, site activation, and vendor oversight across ~30 countries and ~400 sites, coordinating with cross-functional teams to meet regulatory milestones.

Reporting to the VP of Clinical Operations, you will maintain inspection readiness, manage CRO performance, and push the program toward database lock and NDA/BLA submission in a fast-paced

Qualifications

  • 10+ years of progressive Clinical Operations or clinical research experience with significant sponsor-level leadership of global trials.
  • Oncology experience required; breast cancer experience strongly preferred.
  • Demonstrated leadership of large global Phase III studies across multiple regions.
  • Direct experience leading a global Phase III study through late-stage execution and successful NDA and/or BLA submission.
  • Proven experience taking a pivotal study over the finish line.
  • Deep experience with study start-up and global site activation for complex late-stage trials.
  • Extensive experience managing and overseeing global CROs and vendors.
  • Ability to challenge CRO performance, elevate issues, and drive aggressive timelines and deliverables.
  • Experience managing studies of significant size, complexity, enrollment, site footprint, and budget.
  • Ability to anticipate study risks and implement mitigation and recovery strategies.
  • Strong knowledge of ICH/GCP, inspection readiness, documentation, and global trial requirements.
  • Ability to assume ownership with minimal ramp-up or onboarding.
  • Strong leadership, communication, organizational, and cross-functional collaboration skills.
  • Comfort operating in an execution-focused environment with aggressive timelines.

Responsibilities

  • Lead operational execution of a global Phase III breast cancer study from start-up through regulatory milestones.
  • Drive study start-up across ~30 countries and ~400 sites with tracked and achieved timelines.
  • Provide sponsor oversight of CROs and vendors with clear expectations, deliverables, accountability, and escalation.
  • Hold CROs accountable for contractual performance, milestones, quality, enrollment, and timelines.
  • Identify risks and bottlenecks early and implement mitigation strategies.
  • Coordinate cross-functional activities with Clinical Development, Data Management, Biostatistics, Regulatory, Safety, and Quality.
  • Establish and monitor study-level metrics, milestones, risks, dependencies, and vendor performance.
  • Oversee global site activation and start-up strategy.
  • Drive operational decision-making with urgency appropriate for a pivotal program.
  • Maintain inspection-readiness and documentation standards.
  • Manage CRO and vendor escalation and intervene when performance or timelines are at risk.
  • Provide concise status and risk reporting to Clinical Operations and senior leadership.
  • Advance the study toward database lock and NDA/BLA submission.
  • Operate effectively in a fast-moving biotech environment with high accountability.

Job description

Anywhere

Type: Contract

Category: Clinical Ops

Industry: Life Sciences

Workplace Type: Remote

Standard Hours: Open

Description

Remote

Our client is seeking a Director, Clinical Operations to lead the operational execution of a large global Phase III breast cancer study. The role will drive study start-up, site activation, vendor oversight, and cross-functional coordination across approximately 30 countries and 400 sites, advancing the program through key milestones toward database lock and regulatory submission. The Director will report to the VP of Clinical Operations and will operate in a fast-moving environment with established infrastructure from a prior Phase III breast cancer study using the same CRO and some overlapping sites.

Due to client requirements, applicants must be willing and able to work on a w2 basis. For our w2 consultants, we offer a great benefits package that includes Medical, Dental, and Vision benefits, 401k with company matching, and life insurance.

Rate: $150.00 to $160.00/hr. w2

Responsibilities
  • Lead operational execution of a global Phase III breast cancer study from start-up through regulatory milestones.
  • Drive study start-up across ~30 countries and ~400 sites with tracked and achieved timelines.
  • Provide sponsor oversight of CROs and vendors with clear expectations, deliverables, accountability, and escalation.
  • Hold CROs accountable for contractual performance, milestones, quality, enrollment, and timelines.
  • Identify risks and bottlenecks early and implement mitigation strategies.
  • Coordinate cross-functional activities with Clinical Development, Data Management, Biostatistics, Regulatory, Safety, and Quality.
  • Establish and monitor study-level metrics, milestones, risks, dependencies, and vendor performance.
  • Oversee global site activation and start-up strategy.
  • Drive operational decision-making with urgency appropriate for a pivotal program.
  • Maintain inspection-readiness and documentation standards.
  • Manage CRO and vendor escalation and intervene when performance or timelines are at risk.
  • Provide concise status and risk reporting to Clinical Operations and senior leadership.
  • Advance the study toward database lock and NDA/BLA submission.
  • Operate effectively in a fast-moving biotech environment with high accountability.
Experience Requirements
  • 10+ years of progressive Clinical Operations or clinical research experience with significant sponsor-level leadership of global trials.
  • Oncology experience required; breast cancer experience strongly preferred.
  • Demonstrated leadership of large global Phase III studies across multiple regions.
  • Direct experience leading a global Phase III study through late-stage execution and successful NDA and/or BLA submission.
  • Proven experience taking a pivotal study over the finish line.
  • Deep experience with study start-up and global site activation for complex late-stage trials.
  • Extensive experience managing and overseeing global CROs and vendors.
  • Ability to challenge CRO performance, elevate issues, and drive aggressive timelines and deliverables.
  • Experience managing studies of significant size, complexity, enrollment, site footprint, and budget.
  • Ability to anticipate study risks and implement mitigation and recovery strategies.
  • Strong knowledge of ICH/GCP, inspection readiness, documentation, and global trial requirements.
  • Ability to assume ownership with minimal ramp-up or onboarding.
  • Strong leadership, communication, organizational, and cross-functional collaboration skills.
  • Comfort operating in an execution-focused environment with aggressive timelines.

Eliassen Group is committed to building a diverse and inclusive team from a variety of backgrounds, perspectives, and skills. We are an Equal Opportunity and affirmative Action Employer and all employment decisions are based on merit, performance, and business needs. Eliassen does not discriminate on the basis of race, color, gender identity or expression, sexual preference or orientation, sex (including pregnancy, childbirth, and related medical conditions), marital status, creed, religion, physical or mental disability, genetic information, military or veteran status, age, ancestry, national origin, citizenship status, prohibited criminal record inquiries of applicants and employees, or any other category protected by federal, state, or local laws.

Skills, experience, and other compensable factors will be considered when determining pay rate. The pay range provided in this posting reflects a W2 hourly rate; other employment options may be available that may result in pay outside of the provided range.

W2 employees of Eliassen Group who are regularly scheduled to work 30 or more hours per week are eligible for the following benefits: medical (choice of 3 plans), dental, vision, pre-tax accounts, other voluntary benefits including life and disability insurance, 401(k) with match, and sick time if required by law in the worked-in state/locality.

About Eliassen Group: Eliassen Group is a strategic consulting firm that helps organizations reach further and achieve more through our technology, business advisory, and life sciences solutions. For nearly 40 years, we have combined exceptional people, deep domain expertise, and intelligent capabilities to expand our clients’ capacity and accelerate meaningful outcomes. We are driven by a purpose to positively impact the lives of our employees, clients, consultants, and the communities we serve.

Don’t miss out on our referral program! If we hire a candidate that you refer us to then you can be eligible for a $1,000 referral check!

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Director, Clinical Operations – Phase III Oncology
Director, Clinical Operations – Phase III Oncology

Eliassen Group • Salem (OR)

Remote
USD 207,000 - 220,000
Medical benefits
401k with match
Life insurance
Director, Clinical Operations – Phase III Oncology
Director, Clinical Operations – Phase III Oncology

Eliassen Group • United States

Remote
USD 207,000 - 220,000
Medical, Dental, Vision
401k with company matching
Life insurance
Remote Director, Global Clinical Operations (Phase III)
Remote Director, Global Clinical Operations (Phase III)

Eliassen Group • Salem (OR)

Remote
USD 207,000 - 220,000
Medical benefits
401k with match
Life insurance
Director, Global Clinical Operations - Remote
Director, Global Clinical Operations - Remote

Eliassen Group • Boise (ID)

Remote
USD 207,000 - 220,000
Medical Insurance
Dental Insurance
Vision Insurance
+2
Clinical Project Manager - Oncology (Client Dedicated/Remote)
Clinical Project Manager - Oncology (Client Dedicated/Remote)

Syneos Health, Inc. • United States

Remote
USD 120,000 - 135,000
Company car or car allowance
Health benefits (Medical, Dental, Vision)
401(k) company match
+3
Director, Clinical Operations
Director, Clinical Operations

UroGen Pharma, Inc. • United States

On-site
USD 180,000 - 230,000
Medical
Dental
Vision
+3
Clinical Operations Consultant
Clinical Operations Consultant

Leapfrog Bio • United States

Hybrid
USD 100,000 - 140,000
Remote - Regional Clinical Operations Lead
Remote - Regional Clinical Operations Lead

Beacon Hill Staffing Group • United States

Remote
USD 110,208 - 123,984
Remote Global Phase III Oncology Operations Director
Remote Global Phase III Oncology Operations Director

Eliassen Group • United States

Remote
USD 207,000 - 220,000
Medical, Dental, Vision
401k with company matching
Life insurance
Associate Director Clinical Operations
Associate Director Clinical Operations

EPM Scientific • California

On-site
USD 180,000 - 240,000